125 related articles for article (PubMed ID: 26848773)
1. Long-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinoma.
Zhang MX; Hua YJ; Wang HY; Zhou L; Mai HQ; Guo X; Zhao C; Huang WL; Hong MH; Chen MY
Oncotarget; 2016 Apr; 7(16):21287-97. PubMed ID: 26848773
[TBL] [Abstract][Full Text] [Related]
2. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
[TBL] [Abstract][Full Text] [Related]
3. Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
Huang PY; Zeng TT; Ban X; Li MQ; Zhang BZ; Zhu YH; Hua WF; Mai HQ; Zhang L; Guan XY; Li Y
BMC Cancer; 2016 Aug; 16(1):669. PubMed ID: 27549330
[TBL] [Abstract][Full Text] [Related]
4. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.
Li W; Li J; Wang Y; Zhang K; Li N; Tian Z; Ni B; Wang H; Ruan Z
Oncotarget; 2016 Dec; 7(49):80586-80598. PubMed ID: 27811359
[TBL] [Abstract][Full Text] [Related]
6. Tetrandrine Induces Apoptosis in Human Nasopharyngeal Carcinoma NPC-TW 039 Cells by Endoplasmic Reticulum Stress and Ca
Liu KC; Lin YJ; Hsiao YT; Lin ML; Yang JL; Huang YP; Chu YL; Chung JG
Anticancer Res; 2017 Nov; 37(11):6107-6118. PubMed ID: 29061791
[TBL] [Abstract][Full Text] [Related]
7. Caffeic Acid Phenethyl Ester Induces
Chiang KC; Yang SW; Chang KP; Feng TH; Chang KS; Tsui KH; Shin YS; Chen CC; Chao M; Juang HH
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738439
[TBL] [Abstract][Full Text] [Related]
8. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
[TBL] [Abstract][Full Text] [Related]
9. High YBX1 expression indicates poor prognosis and promotes cell migration and invasion in nasopharyngeal carcinoma.
Zhou LL; Ni J; Feng WT; Yao R; Yue S; Zhu YN; Tang HY; Lv LY; Feng JF; Zhu WG
Exp Cell Res; 2017 Dec; 361(1):126-134. PubMed ID: 29024700
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid synthase-associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma.
Li J; Wen Q; Xu L; Wang W; Luo J; Chu S; Xie G; Shi L; Huang D; Li J; Fan S
Hum Pathol; 2014 Dec; 45(12):2447-52. PubMed ID: 25305096
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of GPx2 protein expression in nasopharyngeal carcinoma.
Liu C; He X; Wu X; Wang Z; Zuo W; Hu G
Cancer Biomark; 2017 Jul; 19(3):335-340. PubMed ID: 28453466
[TBL] [Abstract][Full Text] [Related]
12. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
13. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
14. EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.
Fang CY; Wu CC; Hsu HY; Chuang HY; Huang SY; Tsai CH; Chang Y; Tsao GS; Chen CL; Chen JY
Int J Mol Sci; 2015 Jan; 16(2):2530-58. PubMed ID: 25625511
[TBL] [Abstract][Full Text] [Related]
15. Correlations of the expressions of c-Jun and Egr-1 proteins with clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
Zhong JT; Wang HJ; Yu J; Zhang JH; Wang SF; Yang X; Su W
Cancer Biomark; 2017; 19(2):213-220. PubMed ID: 28269757
[TBL] [Abstract][Full Text] [Related]
16. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
Feng X; Lv W; Wang S; He Q
Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
[TBL] [Abstract][Full Text] [Related]
17. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
[TBL] [Abstract][Full Text] [Related]
18. KAI1 overexpression promotes apoptosis and inhibits proliferation, cell cycle, migration, and invasion in nasopharyngeal carcinoma cells.
Guo Z; Wang Y; Yang J; Zhong J; Liu X; Xu M
Am J Otolaryngol; 2017; 38(5):511-517. PubMed ID: 28583320
[TBL] [Abstract][Full Text] [Related]
19. ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma.
Chen RH; Du Y; Han P; Wang HB; Liang FY; Feng GK; Zhou AJ; Cai MY; Zhong Q; Zeng MS; Huang XM
Oncotarget; 2016 Mar; 7(13):16910-22. PubMed ID: 26919245
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.
Liu Z; Liu J; Li L; Nie D; Tao Q; Wu J; Fan J; Lin C; Zhao S; Ju D
PLoS One; 2015; 10(8):e0135236. PubMed ID: 26288183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
